This inventor holds 3 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignee: Cadila Pharmaceuticals Limited. Active years: 2017-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2022
Title: Innovator Chandreshwar Prasad Shukla: Pioneering Therapeutic Cancer Vaccines
Introduction
Chandreshwar Prasad Shukla, a prominent inventor based in Ahmedabad, India, has made significant contributions to the field of cancer treatment through his innovative inventions. With a total of three patents to his name, Shukla is at the forefront of developing therapeutic solutions aimed at combating cancer.
Latest Patents
Shukla's latest patents focus on a groundbreaking therapeutic cancer vaccine. This invention involves vaccine compositions containing cancer cells that express specific antigens. The methodology incorporates excipients and optionally an adjuvant, with the antigen expressed upon exposure to a p38 inducer. This novel approach helps induce a targeted immune response against both homologous and heterologous cancer cells within affected tissues and organs. Moreover, the invention includes detailed methods of preparing these vaccine compositions, showcasing Shukla's commitment to advancing cancer treatment technology.
Career Highlights
Shukla is currently associated with Cadila Pharmaceuticals Limited, a leading name in the pharmaceutical industry. His dedication to research and innovation has positioned him as an influential figure in the development of therapeutic solutions. Through his work, he strives to enhance the effectiveness of cancer treatment and improve patient outcomes.
Collaborations
Shukla collaborates with notable colleagues in his field, including Bakulesh Mafatlal Khamar and Nirav Manojkumar Desai. Together, they contribute to the advancement of medical research and share a common goal of addressing one of the world's most pressing health challenges—cancer.
Conclusion
In summary, Chandreshwar Prasad Shukla stands out as a dedicated inventor in the realm of cancer therapeutics. His innovative approach to vaccine development reflects a deep understanding of immunology and a commitment to improving healthcare solutions. With ongoing efforts and collaborative spirit, Shukla continues to make strides towards transforming cancer treatment and offering hope to patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile